Government response to the third addendum to the Advisory Council on the Misuse of Drugs' report on 2-benzyl benzimidazole and piperidine benzimidazolone opioids.
Follow this news feed:
Mar212024
Response to the third addendum to the ACMD report on 2-benzyl benzimidazole and piperidine benzimidazolone opioids